- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 75.54M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.84B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.86B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $594.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $620.8M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.91B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $3.79B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $583.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $629.7M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.89B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.95B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.63B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.59B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.8B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.75B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 75.9M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $48.5M |
| Capex | Q1 2025 · Mar 31, 2024 | $20M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $156.6M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.60 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.60 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $195.1M |
| Net Income | Q1 2025 · Mar 31, 2024 | $121.4M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $161.2M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $357.4M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $443.1M |
| Revenue | Q1 2025 · Mar 31, 2024 | $800.5M |